⌘K

Home/Filings/4/0001127602-18-009817

4//SEC Filing

BRENNAN DANIEL 4

Accession 0001127602-18-009817

CIK 0001472091other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 8:29 AM ET

Size

5.3 KB

Accession

0001127602-18-009817

Insider Transaction Report

Form 4

Period: 2018-03-01

Edge Therapeutics, Inc.EDGE

Chief Operating Officer

Transactions

Award
Stock Option (Right To Purchase)
2018-03-01+90,000→ 90,000 total
Exercise: $14.98Exp: 2028-03-01→ Common Stock (90,000 underlying)

Footnotes (1)

[F1]This option, representing a right to purchase a total of 90,000 shares of Common Stock, will become exercisable on March 1, 2019, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Edge Therapeutics, Inc.

CIK 0001472091

Entity typeother

Related Parties

1

filerCIK 0001657999

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 8:29 AM ET
Size: 5.3 KB

View on SEC.gov